197 related articles for article (PubMed ID: 28426283)
1. Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity.
Singh V; Connelly ZM; Shen X; De Benedetti A
Cell Cycle; 2017 May; 16(10):915-926. PubMed ID: 28426283
[TBL] [Abstract][Full Text] [Related]
2. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1.
Singh V; Khalil MI; De Benedetti A
Cell Cycle; 2020 Feb; 19(3):363-375. PubMed ID: 31914854
[TBL] [Abstract][Full Text] [Related]
3. Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Int J Cancer; 2019 Aug; 145(4):1055-1067. PubMed ID: 30737777
[TBL] [Abstract][Full Text] [Related]
4. Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR.
Chen Y; Chen CF; Riley DJ; Chen PL
Cell Cycle; 2011 Feb; 10(4):655-63. PubMed ID: 21301226
[TBL] [Abstract][Full Text] [Related]
5. The TLK1-Nek1 axis promotes prostate cancer progression.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Cancer Lett; 2019 Jul; 453():131-141. PubMed ID: 30928383
[TBL] [Abstract][Full Text] [Related]
6. Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest.
Pelegrini AL; Moura DJ; Brenner BL; Ledur PF; Maques GP; Henriques JA; Saffi J; Lenz G
Mutagenesis; 2010 Sep; 25(5):447-54. PubMed ID: 20501547
[TBL] [Abstract][Full Text] [Related]
7. Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control.
Chen Y; Chen PL; Chen CF; Jiang X; Riley DJ
Cell Cycle; 2008 Oct; 7(20):3194-201. PubMed ID: 18843199
[TBL] [Abstract][Full Text] [Related]
8. Nek1 kinase associates with ATR-ATRIP and primes ATR for efficient DNA damage signaling.
Liu S; Ho CK; Ouyang J; Zou L
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2175-80. PubMed ID: 23345434
[TBL] [Abstract][Full Text] [Related]
9. Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint.
Groth A; Lukas J; Nigg EA; Silljé HH; Wernstedt C; Bartek J; Hansen K
EMBO J; 2003 Apr; 22(7):1676-87. PubMed ID: 12660173
[TBL] [Abstract][Full Text] [Related]
10. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
J Virol; 2019 May; 93(9):. PubMed ID: 30787154
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
[TBL] [Abstract][Full Text] [Related]
12. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
Das KC; Dashnamoorthy R
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound activates ataxia telangiectasia mutated- and rad3-related (ATR)-checkpoint kinase 1 (Chk1) pathway in human leukemia Jurkat cells.
Furusawa Y; Iizumi T; Fujiwara Y; Hassan MA; Tabuchi Y; Nomura T; Kondo T
Ultrason Sonochem; 2012 Nov; 19(6):1246-51. PubMed ID: 22571845
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
15. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
[TBL] [Abstract][Full Text] [Related]
16. Tousled-like kinase-dependent phosphorylation of Rad9 plays a role in cell cycle progression and G2/M checkpoint exit.
Kelly R; Davey SK
PLoS One; 2013; 8(12):e85859. PubMed ID: 24376897
[TBL] [Abstract][Full Text] [Related]
17. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
18. Nek1 interacts with Ku80 to assist chromatin loading of replication factors and S-phase progression.
Patil M; Pabla N; Ding HF; Dong Z
Cell Cycle; 2013 Aug; 12(16):2608-16. PubMed ID: 23851348
[TBL] [Abstract][Full Text] [Related]
19. NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin.
Melo-Hanchuk TD; Slepicka PF; Meirelles GV; Basei FL; Lovato DV; Granato DC; Pauletti BA; Domingues RR; Leme AFP; Pelegrini AL; Lenz G; Knapp S; Elkins JM; Kobarg J
Sci Rep; 2017 Jul; 7(1):5445. PubMed ID: 28710492
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
